Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
LST-AI: a Deep Learning Ensemble for Accurate MS Lesion Segmentation.
Wiltgen T, McGinnis J, Schlaeger S, Kofler F, Voon C, Berthele A, Bischl D, Grundl L, Will N, Metz M, Schinz D, Sepp D, Prucker P, Schmitz-Koep B, Zimmer C, Menze B, Rueckert D, Hemmer B, Kirschke J, Mühlau M, Wiestler B. Wiltgen T, et al. Among authors: muhlau m. medRxiv [Preprint]. 2024 Mar 11:2023.11.23.23298966. doi: 10.1101/2023.11.23.23298966. medRxiv. 2024. Update in: Neuroimage Clin. 2024;42:103611. doi: 10.1016/j.nicl.2024.103611 PMID: 38045345 Free PMC article. Updated. Preprint.
Retrospective cohort study to devise a treatment decision score predicting adverse 24-month radiological activity in early multiple sclerosis.
Hapfelmeier A, On BI, Mühlau M, Kirschke JS, Berthele A, Gasperi C, Mansmann U, Wuschek A, Bussas M, Boeker M, Bayas A, Senel M, Havla J, Kowarik MC, Kuhn K, Gatz I, Spengler H, Wiestler B, Grundl L, Sepp D, Hemmer B. Hapfelmeier A, et al. Among authors: muhlau m. Ther Adv Neurol Disord. 2023 Mar 24;16:17562864231161892. doi: 10.1177/17562864231161892. eCollection 2023. Ther Adv Neurol Disord. 2023. PMID: 36993939 Free PMC article.
Early spinal cord pseudoatrophy in interferon-beta-treated multiple sclerosis.
Matusche B, Litvin L, Schneider R, Bellenberg B, Mühlau M, Pongratz V, Berthele A, Groppa S, Muthuraman M, Zipp F, Paul F, Wiendl H, Meuth SG, Sämann P, Weber F, Linker RA, Kümpfel T, Gold R, Lukas C. Matusche B, et al. Among authors: muhlau m. Eur J Neurol. 2023 Feb;30(2):453-462. doi: 10.1111/ene.15620. Epub 2022 Nov 17. Eur J Neurol. 2023. PMID: 36318271
Multicenter Evaluation of AI-generated DIR and PSIR for Cortical and Juxtacortical Multiple Sclerosis Lesion Detection.
Bouman PM, Noteboom S, Nobrega Santos FA, Beck ES, Bliault G, Castellaro M, Calabrese M, Chard DT, Eichinger P, Filippi M, Inglese M, Lapucci C, Marciniak A, Moraal B, Morales Pinzon A, Mühlau M, Preziosa P, Reich DS, Rocca MA, Schoonheim MM, Twisk JWR, Wiestler B, Jonkman LE, Guttmann CRG, Geurts JJG, Steenwijk MD. Bouman PM, et al. Among authors: muhlau m. Radiology. 2023 Apr;307(2):e221425. doi: 10.1148/radiol.221425. Epub 2023 Feb 7. Radiology. 2023. PMID: 36749211 Free PMC article.
Retinal ganglion cell loss is associated with future disability worsening in early relapsing-remitting multiple sclerosis.
Wauschkuhn J, Solorza Buenrostro G, Aly L, Asseyer S, Wicklein R, Hartberger JM, Ruprecht K, Mühlau M, Schmitz-Hübsch T, Chien C, Berthele A, Brandt AU, Korn T, Paul F, Hemmer B, Zimmermann HG, Knier B. Wauschkuhn J, et al. Among authors: muhlau m. Eur J Neurol. 2023 Apr;30(4):982-990. doi: 10.1111/ene.15681. Epub 2023 Jan 29. Eur J Neurol. 2023. PMID: 36635219
Prospective study validating a multidimensional treatment decision score predicting the 24-month outcome in untreated patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis, the ProVal-MS study.
Bayas A, Mansmann U, Ön BI, Hoffmann VS, Berthele A, Mühlau M, Kowarik MC, Krumbholz M, Senel M, Steuerwald V, Naumann M, Hartberger J, Kerschensteiner M, Oswald E, Ruschil C, Ziemann U, Tumani H, Vardakas I, Albashiti F, Kramer F, Soto-Rey I, Spengler H, Mayer G, Kestler HA, Kohlbacher O, Hagedorn M, Boeker M, Kuhn K, Buchka S, Kohlmayer F, Kirschke JS, Behrens L, Zimmermann H, Bender B, Sollmann N, Havla J, Hemmer B; ProVal-MS study group. Bayas A, et al. Among authors: muhlau m. Neurol Res Pract. 2024 Mar 7;6(1):15. doi: 10.1186/s42466-024-00310-x. Neurol Res Pract. 2024. PMID: 38449051 Free PMC article.
131 results